The global breast biopsy device market had a valuation of USD 2.18 billion in 2022. It is projected to reach USD 4.73 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9% during the forecast period. The primary drivers of market revenue growth are the increasing prevalence of breast cancer and growing awareness among women about the importance of early detection. The utilization of breast biopsy equipment is on the rise due to advancements in technology, the demand for minimally invasive procedures, and improvements in healthcare infrastructure in emerging economies.
https://www.reportsanddata.com..../report-detail/breas
Like
Comment
Share
